eISSN: 2299-0046
ISSN: 1642-395X
Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii
Current issue Archive Manuscripts accepted About the journal Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications
Share:
Send email
Share:
Review paper

Systematic review and network meta-analysis of the risk of malignancy with biologic therapies and selective Janus kinase-1 inhibitors in atopic dermatitis

Daud Manzar
1
,
Nikhil Nair
1
,
Emmanuel Suntres
2
,
Myanca Rodrigues
3
,
Logain Alghanemi
4, 5
,
Mohannad Abu-Hilal
4

  1. Michael G. DeGroote School of Medicine, McMaster University, Hamilton, Ontario, Canada
  2. Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada
  3. Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada
  4. Division of Dermatology, McMaster University, Hamilton, Ontario, Canada
  5. Dermatology Department, King Abdulaziz University, Jeddah, Saudi Arabia
Adv Dermatol Allergol
DOI: https://doi.org/10.5114/ada.2024.141125
Online publish date: 2024/07/02
Article files
- Systematic (1).pdf  [0.13 MB]
- Kopia Supplement 1.xlsx  [0.17 MB]
- Supplement 2.pdf  [0.28 MB]
Get citation
 
 
1. Spergel JM, Paller AS. Atopic dermatitis and the atopic march. J Allergy Clin Immunol 2003; 112 (6, Suppl): S118-27.
2. Wang H, Diepgen T. Atopic dermatitis and cancer risk. Br J Dermatol 2006; 154: 205-10.
3. Jensen AO, Svaerke C, Körmendiné Farkas D, et al. Atopic dermatitis and risk of skin cancer. Am J Clin Dermatol 2012; 13: 29-36.
4. Arana A, Wentworth C, Fernández-Vidaurre C, et al. Incidence of cancer in the general population and in patients with or without atopic dermatitis in the U.K. Br J Dermatol 2010; 163: 1036-43.
5. Li Z, Chen L, Qin Z. Paradoxical roles of IL-4 in tumor immunity. Cell Mol Immunol 2009; 6: 415-22.
6. Little AC, Pathanjeli P, Wu Z, et al. IL-4/IL-13 stimulated macrophages enhance breast cancer invasion via rho-GTPase regulation of synergistic VEGF/CCL-18 signaling. Front Oncol 2019; 9: 456.
7. Fujisawa T, Joshi BH, Puri RK. IL-13 regulates cancer invasion and metastasis through IL-13Rα2 via ERK/AP-1 pathway in mouse model of human ovarian cancer. Int J Cancer 2012; 131: 344-56.
8. Sabaawy HE, Ryan BM, Khiabanian H, Pine SR. JAK/STAT of all trades: linking inflammation with cancer development, tumor progression and therapy resistance. Carcinogenesis 2021; 42: 1411-9.
9. Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021; 372: n71.
10. Sterne JAC, Savoviæ J, Page MJ, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 2019; 366: l4898.
11. StataCorp. Stata Statistical Software. College Station, TX: StataCorp LLC; 2021.
12. White IR, Barrett JK, Jackson D, Higgins JPT. Consistency and inconsistency in network meta-analysis: model estimation using multivariate meta-regression. Res Synth Methods 2012; 3: 111-25.
13. White IR. Network meta-analysis. Stata J 2015; 15: 951-85.
14. Chaimani A, Higgins JPT, Mavridis D, et al. Graphical tools for network meta-analysis in STATA. PLoS One 2013; 8: e76654.
15. Chaimani A, Mavridis D, Salanti G. A hands-on practical tutorial on performing meta-analysis with Stata. BMJ Ment Health 2014; 17: 111-6.
16. Higgins JPT, Jackson D, Barrett JK, et al. Consistency and inconsistency in network meta-analysis: concepts and models for multi-arm studies. Res Synth Methods 2012; 3: 98-110.
17. Chaimani A, Salanti G. Visualizing assumptions and results in network meta-analysis: the Network Graphs Package. Stata J 2015; 15: 905-50.
18. Dhillon S. Tofacitinib: a review in rheumatoid arthritis. Drugs 2017; 77: 1987-2001.
19. Ytterberg SR, Bhatt DL, Mikuls TR, et al. Cardiovascular and cancer risk with tofacitinib in rheumatoid arthritis. N Engl J Med 2022; 386: 316-26.
20. Parikh-Patel A, White RH, Allen M, Cress R. Risk of cancer among rheumatoid arthritis patients in California. Cancer Causes Control 2009; 20: 1001-10.
21. Nocturne G, Pascaud J, Ly B, et al. JAK inhibitors alter NK cell functions and may impair immunosurveillance against lymphomagenesis. Cell Mol Immunol 2020; 17: 552-3.
22. Ouzzani M, Hammady H, Fedorowicz Z, et al. Rayyan – a web and mobile app for systematic reviews. Syst Rev 2016; 5: 210.
23. Nikolakopoulou A, Higgins JP, Papakonstantinou T, et al. CINeMA: an approach for assessing confidence in the results of a network meta-analysis. PLoS Med 2020; 17: e1003082.
Copyright: © 2024 Termedia Sp. z o. o. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
FEATURED PRODUCTS
BOOKS
• Atopowe Zapalenie Skóry • Choroby alergiczne w praktyce lekarza rodzinnego • Alergologia – kompendium
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2024 Termedia Sp. z o.o.
Developed by Bentus.